Quentin Lepiller
Overview
Explore the profile of Quentin Lepiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spehner L, Orillard E, Falcoz A, Lepiller Q, Bouard A, Almotlak H, et al.
BMJ Oncol
. 2025 Jan;
2(1):e000054.
PMID: 39886486
Objective: Vaccinated patients with cancer in follow-up studies showed a high seropositivity rate but impaired antibody titres and T cell responses following mRNA vaccine against COVID-19. Besides clinical characteristics and...
2.
Legrand M, Louveau B, Macagno N, Mancini M, Kazakov D, Pissaloux D, et al.
Histopathology
. 2024 Nov;
86(4):571-584.
PMID: 39564735
Aims: Sebaceous neoplasms constitute a group of adnexal tumours, including sebaceous adenoma, sebaceoma and sebaceous carcinoma. Although mismatch repair deficiency may be observed, the nature of the genetic alterations contributing...
3.
Pretet J, Baraquin A, Chung P, Puget L, Dhillon S, Tkachenka Y, et al.
J Med Virol
. 2024 Oct;
96(10):e29961.
PMID: 39422358
Cervical cancer screening is a cornerstone of cervical cancer elimination. Detection of high-risk human papillomavirus (hrHPV) is recommended as the first step in screening provided that the assay used has...
4.
Jacquin E, Saunier M, Lepiller Q, Monnien F, Mauny F, Ramanah R, et al.
J Med Virol
. 2024 Sep;
96(9):e29875.
PMID: 39221528
The natural history of cervical cancer is closely linked to that of high-risk human papillomaviruses (HPV) infection. It is recognized that upon HPV DNA integration, partial or complete loss of...
5.
Contamine M, Ader F, Lepiller Q, Martha B, Cagnon-Chapalain J, Leturnier P, et al.
Infect Dis (Lond)
. 2024 Jun;
56(10):842-850.
PMID: 38822453
Background: Systematic treatment with intravenous acyclovir is usually given when varicella zoster virus (VZV) DNA is isolated in cerebrospinal fluid (CSF), indicating central nervous system (CNS) involvement. Our study aimed...
6.
Puget L, Node J, Cael B, Bamoulid J, Coaquette A, Pretet J, et al.
Ann Pharm Fr
. 2024 Mar;
82(5):755-761.
PMID: 38492661
Cytomegalovirus (CMV) excretion in urine is frequently observed in clinical practice. However, the specific circumstances and pathophysiological mechanisms underlying this shedding remain largely unknown. Here, we address some of the...
7.
Bressollette-Bodin C, Touze A, Jung A, Herfs M, Lepiller Q, Bravo I, et al.
Virologie (Montrouge)
. 2024 Mar;
28(1):44-54.
PMID: 38450668
No abstract available.
8.
Pretet J, Arroyo Muhr L, Cuschieri K, Fellner M, Correa R, Picconi M, et al.
J Clin Virol
. 2024 Feb;
171:105657.
PMID: 38401369
Background: Some high-grade cervical lesions and cervical cancers (HSIL+) test negative for human papillomavirus (HPV). The HPV-negative fraction varies between 0.03 % and 15 % between different laboratories. Monitoring and...
9.
Node J, Dor F, Puget L, Ramanah R, Cot S, Bibeau F, et al.
J Med Virol
. 2024 Feb;
96(2):e29465.
PMID: 38323725
The positive clinical threshold of human papillomavirus (HPV) tests validated for primary cervical cancer screening (CCS) is designed to offer an optimal balance between clinical sensitivity and specificity. However, there...
10.
Andre-Garnier E, Bocket L, Bourlet T, Hocqueloux L, Lepiller Q, Maillard A, et al.
J Antimicrob Chemother
. 2024 Jan;
79(3):578-588.
PMID: 38269616
Objectives: As many disparities in the clinical use of HIV DNA sequencing are observed, a DELPHI-type consensus was initiated in France to homogenize use, techniques and interpretation of results. Methods:...